Route Mobile Ltd. Share Price

Jubilant Pharmova Steadies After Fall, NCD Call Ahead

Jubilant Pharmova shares closed nearly flat at Rs 931.90 on Friday, stabilising after Thursday's sharp 4.35% fall, as the pharma and contract manufacturing company heads into a board meeting on October 12 to weigh raising funds via non-convertible debentures on private placement. Thursday's drop came amid broader market weakness, but it also sets the stage for this week's board decision on an NCD issuance, a debt-based fundraising route rather than fresh equity. Jubilant Pharmova runs a diversified business spanning contract manufacturing of sterile injectables, radiopharmaceuticals, and its own branded formulations and allergy therapy franchise, a mix needing steady capital for plant upgrades and capacity expansion across geographies. Contract development and manufacturing businesses live and die by passing regulatory inspections and keeping capacity running at scale, making timely capital access important for staying competitive against global peers. Choosing debt over equity suggests management wants to avoid diluting shareholders while funding capex, though an NCD also adds interest obligations the company must service regardless of near-term earnings swings, a trade-off investors in capital-intensive pharma watch closely. The stock has ranged between Rs 786.05 and Rs 1,184.80 over the past 52 weeks, with a market cap of around Rs 14,845 crore, trading well below its yearly high. With the board decision days away, how the funds are deployed, and at what cost, will likely shape sentiment more than Thursday's one-day dip. Disclosure: Palash Kag, Proprietor, Sarathi Research (SEBI Reg. No. INH000012740). No position held in Jubilant Pharmova. This article is for educational and informational purposes only and does not constitute investment advice or a recommendation to buy, sell, or hold any security. Please consult a registered advisor before making investment decisions.

See More

Tata Power partners For floating solar technology in India

Tata Power Company Limited has partnered with Norway-based Ocean Sun to introduce and evaluate membrane-based floating solar technology in India. As part of the collaboration, the companies plan to conduct a 300 kWp pilot project at the Mulshi reservoir in Maharashtra. Unlike conventional ground-mounted solar projects, floating solar installations utilise water surfaces. The pilot will help evaluate whether the technology can be deployed effectively under Indian operating conditions. Why this matters India's renewable-energy expansion requires not only additional generation capacity but also efficient utilisation of available land and infrastructure. Floating solar potentially creates another route for renewable capacity addition, particularly around reservoirs and hydropower assets. However, this is currently a pilot project, so investors should not treat the announcement as a large immediate revenue opportunity. Its significance depends on whether the technology proves technically and commercially viable and is subsequently deployed at larger scale. What to monitor next- Performance of the 300 kWp pilot. Potential commercial-scale deployment. Cost per MW versus conventional solar. Additional floating-solar projects. Tata Power's overall renewable capacity additions. Renewable segment profitability and cash flows. My analytical view: The partnership is strategically interesting because it gives Tata Power exposure to an alternative floating-solar technology. However, the current project is small, making successful testing and eventual scalability more important than the initial capacity announced. SEBI RA Disclaimer: Umang Rajesh Bhutada is a SEBI-registered Research Analyst (INH000023001). This content is for educational and informational purposes only and is not investment advice. Securities investments are subject to market risks. Please consult a qualified financial professional before making investment decisions.

See More

Runwal Enterprises Plans ₹225 Cr Subsidiary Investment

WAL ENTERPRISES: Runwal Enterprises Ltd. has entered into agreements for making investments in its subsidiaries through non-convertible debentures (NCDs), with the total investment amounting to ₹225 crore. The proposed investment is intended to support loan repayment requirements of the company’s wholly owned subsidiaries. The capital deployment through NCDs provides a structured funding route within the group and is aimed at addressing the repayment obligations of the respective subsidiaries. The transaction represents an internal capital allocation by Runwal Enterprises towards its wholly owned subsidiaries, with the funds intended for specific loan repayment purposes rather than a new external business acquisition or expansion announced as part of the transaction. Non-convertible debentures are debt instruments that carry defined terms and do not provide the holder with a conversion option into equity shares. The financial and operational impact of the investment will depend on the terms of the NCDs, repayment arrangements, subsidiary-level requirements and the broader financial position of the group. The company may provide further details regarding the investment structure, tenure, interest terms and deployment through subsequent corporate disclosures, as applicable. Market participants may track further company announcements for updates on the investment, subsidiary loan repayments and related financial developments. This information is shared strictly as a corporate and market update for informational purposes and should not be considered investment advice, research analysis, or a recommendation to buy or sell any security.

See More

Tata Consultancy Services Ltd. and US Immigration policy

is consolidating near ₹2,077 after the recent decline, while the latest U.S. immigration action has added a fresh sentiment overhang for Indian IT companies. The development relates to the PERM route for employment-based permanent residency and may increase uncertainty around employee mobility, compliance and local hiring in the United States. Technically, the one-hour chart remains weak. Price is below the Tenkan-sen at ₹2,101 and Kijun-sen near ₹2,093, while the Ichimoku cloud between ₹2,089 and ₹2,097 has become immediate resistance. The current base near ₹2,060 is holding for now, but buyers need to reclaim the cloud before the structure can improve. ₹2,060 remains the key support. A break below it can bring ₹2,030 into focus. On the upside, ₹2,101 is the first level that needs to be crossed for short-term recovery. The immigration development is more of a cost and execution concern than an immediate change to delivery capability, but it can keep sentiment cautious until there is greater policy clarity.

See More

Allcargo Logistics Ltd planned CEO transition

The company announced that MD & CEO Ketan Kulkarni will resign effective December 31, 2026 to take on a new group role, while Vijay Nehra has been appointed Chief Transformation Officer and MD‑designate from October 1, 2026 and is slated to become MD & CEO from January 1, 2027 (subject to shareholder approval), marking a planned succession after the group’s restructuring into four listed entities. Operationally, Allcargo swung back to a Q1 FY27 profit (PAT ~₹15 crore) after the NCLT‑approved restructuring that consolidated its domestic express and consultative logistics businesses, with domestic express volumes up nearly 7% YoY to over 312,000 tonnes; management has guided to crack double‑digit EBITDA margins by FY28, leveraging AI for fleet turnaround prediction, route optimisation and yield management. Shares were trading around ₹10.04–₹10.19 on October 8, with a market capitalisation near ₹2,700–₹2,800 crore and a 52‑week range of ₹8.01–₹14.98.

See More